Adenocarcinoma: all 1,996 studies
Page 18 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT01537107Phase 1
- Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 DissectionStatus unknownNCT01534546Phase 3
- C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate AdenocarcinomaCompletedNCT01530269Phase 2
- Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic AdenocarcinomaCompletedNCT01526135Phase 3
- Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric JunctionStatus unknownNCT01523015Phase 2/3
- Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) TrialActive, not recruitingNCT01512589Phase 2
- Validation of Colon Biomarkers for the Early Detection of Colorectal AdenocarcinomaCompletedNCT01511653
- A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.WithdrawnNCT01510561Phase 1
- A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic CancerCompletedNCT01506973Phase 1/2
- Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
- Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
- Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never SmokersStatus unknownNCT01502202Phase 2
- Interest of Saline MR Peritoneography for Pre-operative Assessment of Rectal CancerCompletedNCT01497457Not applicable
- Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for AdenocarcinomaCompletedNCT01491698Phase 3
- Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line ChemotherapyTerminatedNCT01484860Phase 2
- Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment StrategyStatus unknownNCT01482585
- Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric CancerTerminatedNCT01476553Not applicable
- Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic AdenocarcinomaCompletedNCT01474564
- A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic AdenocarcinomaCompletedNCT01472198Phase 2
- Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachCompletedNCT01472029Phase 2
- Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric JunctionStatus unknownNCT01468389Phase 3
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersCompletedNCT01460134Phase 1
- Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic CarcinomaCompletedNCT01456585Phase 1
- Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal CancerCompletedNCT01455831Phase 3
- Clinical Outcomes of Endoscopic Resection for Treating WHYX LesionCompletedNCT01451034Phase 4
- Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid TumorsCompletedNCT01447732Phase 1
- Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the ProstateActive, not recruitingNCT01444820Phase 3
- MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaCompletedNCT01443065Phase 2
- Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerCompletedNCT01440998Phase 1
- Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head CancerTerminatedNCT01419002Phase 3
- The Study of Metastatic Pancreatic AdenocarcinomaCompletedNCT01415713Phase 1/2
- FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaCompletedNCT01413022Phase 1
- A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic AdenocarcinomaCompletedNCT01410968Phase 1
- Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With BevacizumabCompletedNCT01405430Not applicable
- Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ AdenocarcinomaCompletedNCT01404156Phase 2/3
- Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal CancerWithdrawnNCT01403103Early Phase 1
- Estrogen Receptor Beta Agonists (Eviendep) and Polyp RecurrenceCompletedNCT01402648Phase 1/2
- Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of RectumCompletedNCT01396928
- Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)CompletedNCT01393483
- Esophageal Protocol for Detection of Neoplasia in the Digestive TractCompletedNCT01391208Phase 1
- Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic CancerCompletedNCT01389440Phase 2
- Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract AdenocarcinomaCompletedNCT01389414Phase 2
- FOLFIRINOX Plus IPI-926 for Advanced Pancreatic AdenocarcinomaCompletedNCT01383538Phase 1
- Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT01379807Phase 2
- NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic CancerCompletedNCT01369420Phase 2
- Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionCompletedNCT01360086Phase 2
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric AdenocarcinomaTerminatedNCT01351038Phase 2
- Immunochemoradiotherapy in Patients With Pancreatic CancerCompletedNCT01342224Phase 1
- Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer PatientsCompletedNCT01336062Phase 1/2
- Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic MassesCompletedNCT01315548
- Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal AdenocarcinomaWithdrawnNCT01302613Phase 1/2
- Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)WithdrawnNCT01301612Phase 2
- Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable CancerCompletedNCT01295086Not applicable
- Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCompletedNCT01294826Phase 1
- Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric AdenocarcinomaCompletedNCT01286766Phase 2
- A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal AdenocarcinomasCompletedNCT01284231Phase 1
- Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric CancerStatus unknownNCT01283217Phase 3
- Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic ResectionCompletedNCT01278368Not applicable
- Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the PancreasTerminatedNCT01276613Early Phase 1
- Gene Therapy of Pancreatic Ductal AdenocarcinomaCompletedNCT01274455Phase 1
- Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)TerminatedNCT01271322Phase 2
- Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal CancerWithdrawnNCT01270438Phase 2
- Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based TreatmentCompletedNCT01262482Phase 2
- Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the OesophagusTerminatedNCT01262183Phase 2
- A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy VolunteersCompletedNCT01261754Phase 1
- Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma ProstateCompletedNCT01255891Phase 2
- Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung AdenocarcinomaStatus unknownNCT01249066
- Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung AdenocarcinomaStatus unknownNCT01249053
- Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's EsophagusCompletedNCT01238042Phase 1
- Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryCompletedNCT01234935Phase 2
- Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic AdenocarcinomaCompletedNCT01233375Phase 2
- Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)CompletedNCT01220752Phase 2
- Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic AdenocarcinomaCompletedNCT01219829
- ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate AdenocarcinomaCompletedNCT01219790Phase 1
- Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerCompletedNCT01216813
- FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal CancerCompletedNCT01206530Phase 1/2
- Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal CancerTerminatedNCT01198535Phase 1
- Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the PancreasCompletedNCT01188785Phase 1
- AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic CancerStatus unknownNCT01182246Phase 1/2
- Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)Status unknownNCT01180153Phase 2
- Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer PatientsActive, not recruitingNCT01171300Not applicable
- Observational Study on the Management of Patients With Non Small Cell Lung Cancer AdenocarcinomaCompletedNCT01167972
- A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric AdenocarcinomaCompletedNCT01166490Phase 1
- Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic AdenocarcinomaCompletedNCT01161186Phase 1
- School Response to Families Who Have Children With CancerWithdrawnNCT01148082
- A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsStatus unknownNCT01131429Phase 2
- First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.CompletedNCT01129310Phase 2
- Frequency of Methods of Local Invasion of Pancreatic AdenocarcinomaCompletedNCT01129167
- Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric CancerCompletedNCT01123811Phase 2
- Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction CancerTerminatedNCT01123473Phase 2
- Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT01117935Not applicable
- Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT01107639Phase 3
- A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma HistologyCompletedNCT01106781
- A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation StatusStatus unknownNCT01100827
- Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)TerminatedNCT01096732Phase 2
- Tesetaxel as Second-line Therapy for Patients With Advanced Gastric CancerStatus unknownNCT01095120Phase 2
- Chemoradiation and Panitumumab for Esophageal CancerCompletedNCT01077999Phase 2
- Lymph Fluid and Blood Collection for Identification of Novel BiomarkersTerminatedNCT01075607
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01074411Phase 1